Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1982 Sep 1;127(5):368–372.

Torsades de pointes, a common arrhythmia, induced by medication.

P T Ko, S Gulamhusein, W J Kostuk, G J Klein
PMCID: PMC1862015  PMID: 7104914

Abstract

Between May 1980 and April 1981 four patients were referred to one hospital with syncope or recurrent ventricular fibrillation while taking antiarrhythmic or phenothiazine drugs. In all the patients ventricular tachyarrhythmias with the characteristics of torsades de pointes were documented in association with prolonged QT intervals. With removal of the offending agent (in all the patients) supplemented by temporary overdrive pacing (in two patients) the tachyarrhythmias subsided. This study suggests that drug-induced torsades de pointes is an important clinical entity that occurs more frequently than has been suspected.

Full text

PDF
372

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Mason J. W. Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia. Am J Med. 1978 Apr;64(4):715–718. doi: 10.1016/0002-9343(78)90595-8. [DOI] [PubMed] [Google Scholar]
  2. Cramér G. Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. Acta Med Scand Suppl. 1968;490:5–102. [PubMed] [Google Scholar]
  3. Dessertenne F. La tachycardie ventriculaire à deux foyers opposés variables. Arch Mal Coeur Vaiss. 1966 Feb;59(2):263–272. [PubMed] [Google Scholar]
  4. Fowler N. O., McCall D., Chou T. C., Holmes J. C., Hanenson I. B. Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol. 1976 Feb;37(2):223–230. doi: 10.1016/0002-9149(76)90316-7. [DOI] [PubMed] [Google Scholar]
  5. Jenzer H. R., Hagemeijer F. Quinidine syncope: torsade de pointes with low quinidine plasma concentrations. Eur J Cardiol. 1976 Dec;4(4):447–451. [PubMed] [Google Scholar]
  6. Khan M. M., Logan K. R., McComb J. M., Adgey A. A. Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongation. Am J Cardiol. 1981 Jun;47(6):1301–1308. doi: 10.1016/0002-9149(81)90263-0. [DOI] [PubMed] [Google Scholar]
  7. Koster R. W., Wellens H. J. Quinidine-induced ventricular flutter and fibrillation without digitalis therapy. Am J Cardiol. 1976 Oct;38(4):519–523. doi: 10.1016/0002-9149(76)90471-9. [DOI] [PubMed] [Google Scholar]
  8. Krikler D. M., Curry P. V. Torsade De Pointes, an atypical ventricular tachycardia. Br Heart J. 1976 Feb;38(2):117–120. doi: 10.1136/hrt.38.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Meltzer R. S., Robert E. W., McMorrow M., Martin R. P. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. Am J Cardiol. 1978 Dec;42(6):1049–1053. doi: 10.1016/0002-9149(78)90694-x. [DOI] [PubMed] [Google Scholar]
  10. Miller D. S., Blount A. W., Jr Quinidine-induced recurrent ventricular fibrillation: (quinidine syncope) treated with transvenous pacemaker. South Med J. 1971 May;64(5):597–601. doi: 10.1097/00007611-197105000-00019. [DOI] [PubMed] [Google Scholar]
  11. Motté G., Coumel P., Abitbol G., Dessertenne F., Slama R. Le syndrome QT long et syncopes par "torsades de pointe". Arch Mal Coeur Vaiss. 1970 Jun;63(6):831–853. [PubMed] [Google Scholar]
  12. Nicholson W. J., Martin C. E., Gracey J. G., Knoch H. R. Disopyramide-induced ventricular fibrillation. Am J Cardiol. 1979 May;43(5):1053–1055. doi: 10.1016/0002-9149(79)90374-6. [DOI] [PubMed] [Google Scholar]
  13. Ranquin R., Parizel G. Ventricular fibrillo-flutter ("torsade de pointe"): an established electrocardiographic and clinical entity. Angiology. 1977 Feb;28(2):115–118. doi: 10.1177/000331977702800207. [DOI] [PubMed] [Google Scholar]
  14. Reynolds E. W., Vander Ark C. R. Quinidine syncope and the delayed repolarization syndromes. Mod Concepts Cardiovasc Dis. 1976 Aug;45(8):117–122. [PubMed] [Google Scholar]
  15. SELZER A., WRAY H. W. QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS. Circulation. 1964 Jul;30:17–26. doi: 10.1161/01.cir.30.1.17. [DOI] [PubMed] [Google Scholar]
  16. Schoonmaker F. W., Osteen R. T., Greenfield J. C., Jr Thioridazine (mellaril)-induced ventricular tachycardia controlled with an artificial pacemaker. Ann Intern Med. 1966 Nov;65(5):1076–1078. doi: 10.7326/0003-4819-65-5-1076. [DOI] [PubMed] [Google Scholar]
  17. Schwartz P. J., Periti M., Malliani A. The long Q-T syndrome. Am Heart J. 1975 Mar;89(3):378–390. doi: 10.1016/0002-8703(75)90089-7. [DOI] [PubMed] [Google Scholar]
  18. Slama R., Motte G., Coumel P., Dessertenne F. Le syndrome "allongement of QT et syncopes par torsades de pointes". Laval Med. 1971;42(4):353–366. [PubMed] [Google Scholar]
  19. Smith W. M., Gallagher J. J. "Les torsades de pointes": an unusual ventricular arrhythmia. Ann Intern Med. 1980 Oct;93(4):578–584. doi: 10.7326/0003-4819-93-4-578. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES